Congress remains divided on budget negotiations as government shutdown looms: ‘Our financial ship is sinking’
If Congress does not reach an agreement before 12:01 a.m. on Oct. 1, the government will shut down.
Poll: Overwhelming majorities express concerns about Biden, Trump ahead of 2024 race
Trump’s lead has expanded in the GOP presidential contest, while Biden and Trump are tied in a hypothetical general election matchup.
International and small cap stocks face a delayed recovery. Here are two cash cow ETFs to ride out the volatility
The higher-for-longer rate path outlined by the Federal Reserve this past week may mean a delayed recovery for small caps, one investor says.
Writers strike negotiations hung up on language over AI, sources say
Studio executives were not present for the talks Saturday, two sources familiar with the negotiations said. Bargaining will enter a fifth day Sunday.
Going beyond Tesla: ETF bets solely on electric vehicle makers
Defiance ETFs is trying to change up the EV ETF market with an all-electric carmaker fund.
Sen. John Fetterman is first Democratic senator to tell Sen. Bob Menendez to resign after bribery indictment
Sen. John Fetterman called on U.S. Sen. Bob Menendez to resign because of his indictment on federal bribery charges.
Scooter company Bird delisted from NYSE after stock collapse, will trade over the counter
Once valued at $2.5 billion by private investors, scooter company Bird is moving its stock off the New York Stock Exchange after the shares collapsed
More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached
Kaiser Permanente is the largest nonprofit health-care organization in the U.S. serving nearly 13 million patients.
A key benchmark for smaller stocks could lose its 2023 gains, and that could mean trouble for bigger names
The Russell 2000 is little over 1% higher for 2023, which some analysts believe could be a signal of underlying market volatility.
CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer’s Abrysvo, from September through January.
